The Latest Cardiac and Vascular News
Complementary technology to orbital atherectomy expands CSI’s vessel prep market opportunity ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today it has made significant progress towards the commercialization of […]
The objective of this study is to obtain data on the technical feasibility, safety, and efficacy of the second-generation eCLIPs products for the treatment of bifurcation aneurysms. VANCOUVER, British Columbia–(BUSINESS WIRE)–Evasc Neurovascular, a pioneer in the development of disruptive endovascular treatments for cerebral aneurysms, announced today the enrollment of the […]
Two novel targets identified through the existing collaboration have already been added to AstraZeneca’s portfolio LONDON, Jan. 13, 2022 /PRNewswire/ — BenevolentAI, a leading clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery collaboration with AstraZeneca, doubling the number of disease areas being explored through the partnership. The three-year expansion includes an […]
CARLSBAD, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the company’s attendance at the 27th Annual AF Symposium. Cases performed at Na Homolce Hospital in Prague, Czech Republic, by physicians Jacob […]
NDA submitted for sotagliflozin in heart failure with an expected launch in 2H 2022, if approved LX9211 neuropathic pain Phase 2 studies expected to read out in 1H 2022 THE WOODLANDS, Texas, Jan. 13, 2022 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) is outlining major potential value drivers for 2022 at […]
BOSTON, Jan. 13, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (NASDAQ: CINC) today announced the appointment of the independent member June Lee, M.D. to the company’s Board of Directors. Dr. Lee brings decades of leadership experience in the biotechnology and pharmaceutical industry and has served in numerous executive and board […]
Perceval Sutureless Aortic Heart Valve Received Approval in China to Treat Patients with Aortic Valve Disease LONDON–(BUSINESS WIRE)–CORCYM, the medical device company dedicated to providing patients and cardiac surgeons with the best solutions to fight structural heart disease, announces today the first Perceval implant in China, after the recent approval from the […]
– EnSite™ X EP System with EnSite Omnipolar Technology (OT) provides a 360-degree view of the heart, regardless of catheter orientation, for cardiac mapping without compromise ABBOTT PARK, Ill., Jan. 12, 2022 /PRNewswire/ — Abbott (NYSE: ABT) today announced it has received clearance from the U.S. Food and Drug Administration for the EnSite™ X EP System […]
Provides Broad Coverage for Use of TNX-102 for the Treatment of Human Subjects with Any Health Condition Patent Term to 2039, Exclusive of Any Possible Extensions MORRISVILLE, N.C., Jan. 12, 2022 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing, and commercializing products that […]
Helping patients stick with their care plans and accurately communicate with their providers key to the best quality of life possible, says heart failure nurse specialist PORTLAND, Maine–(BUSINESS WIRE)–A heart failure nurse specialist saw a need for her patients to track the specific metrics needed for their physical well-being, empowering […]
